Monica Balzarotti, MD^1*, Umberto Ricardi, MD^2*, Michele Spina, MD³, Andrea Evangelista, MSc^4*, Alessandra Tucci, MD^5*, Federica Cavallo, MD^6*, Manuela Zanni, MD^7*, Annalisa Arcari, MD^8*, Vittorio Ruggero Zilioli, MD^9*, Roberto Sartori, MD^10*, Francesco Merli, MD^11*, Francesca Re, MD^12*, Umberto Vitolo, MD¹³, Maria Assunta Deidda, MD^14*, Luca Melis, MD^15*, Daniela Dessì, MD^16*, Marcello Rodari, MD^17*, Armando Santoro, MD^18*, Gianluca Gaidano, MD, PhD¹⁹, Giovannino Ciccone, MD^20*, Stephane Chauvie, PhD^21* and Maria Giuseppina Cabras, MD^16*

¹Department of Hematology, Humanitas Clinical and Research Center IRCCS, Rozzano, Italy
²Radiation Oncology, Department of Oncology, University of Turin, Turin, ITA
³Dept of Medical Oncology, IRCCS CRO Aviano, Aviano (PN), Italy
⁴Città Della Salute E Della Scienza, Torino, ITA
⁵Department of Hematology, ASST Spedali Civili, Brescia, Italy
⁶Division of Hematology , AOU Città della Salute e della Scienza di Torino, Torino, Italy
⁷Division of Hematology, Azienda Ospedaliera Santi Antonio e Biagio e Cesare Arrigo, Alessandria, Italy
⁸Hematology Unit, Ospedale Guglielmo da Saliceto, Piacenza, Italy
⁹Division of Hematology, ASST Grande Ospedale Metropolitano Niguarda, Milan, IT-MI, Italy
¹⁰Ospedale di Castelfranco Veneto - Ematologia, Castelfranco Veneto, ITA
¹¹AUSL-IRCCS, Reggio Emilia, Reggio Emilia, Italy
¹²Hematology and CTMO, Azienda Ospedaliera-Universitaria di Parma, Parma, Italy
¹³Candiolo Cancer Institute, FPO-IRCCS, Candiolo (Torino), Italy
¹⁴Department of Radiotherapy, Regional Oncological Businco Hospital, Cagliari, Italy
¹⁵Ospedale Oncologico "A. Businco" Cagliari ·, Nuclear Medicin Unit, Cagliari, Italy
¹⁶Division of Hematology, Ospedale Oncologico Armando Businco, Cagliari, Italy
¹⁷Nuclear Medicine, IRCCS Humanitas Research Hospital, Milano, Italy
¹⁸Humanitas University and IRCCS Humanitas Research Hospital, Humanitas Cancer Center, Milan, Italy
¹⁹Division of Hematology, Department of Translational Medicine, Università del Piemonte Orientale, Novara, Italy
²⁰Unit of Clinical Epidemiology, Azienda Ospedaliera e Universitaria Città della Salute e della Scienza and CPO Piemonte, Torino, Italy
²¹Medical Phyhsics Department, S. Croce Hospital, Cuneo, Italy

Sirpa Leppa, MD, PhD¹, Judit M. Jørgensen, MD, PhD^2*, Marja-Liisa Karjalainen-Lindsberg, MD, PhD^3*, Klaus Beiske, MD, PhD^4*, Mette Pedersen, MD, PhD^5*, Kristina Drott, MD, PhD^6*, Annika Pasanen, MD, PhD^1*, Kristiina Karihtala, MD^1*, Susanna Mannisto, MD, PhD^1*, Leo Meriranta, MD^1*, Bente Wold, MD^4*, Marianne Brodtkorb, MD, PhD^7*, Unn Merete Fagerli, MD, PhD^8*, Thomas S. Larsen, MD, PhD^9*, Lars Munksgaard, MD^10*, Kaisa Sunela, MD, PhD^11*, Øystein Fluge, MD, PhD^12*, Sirkku Jyrkkio, MD, PhD^13*, Peter de Nully Brown, MD, PhD^14* and Harald Holte, MD, PhD⁴

¹University of Helsinki and Helsinki University Hospital, Helsinki, Finland
²Aarhus University Hospital, Aarhus, Denmark
³Helsinki University Hospital, Helsinki, Finland
⁴Oslo University Hospital, Oslo, Norway
⁵Rigshospitalet, Copenhagen University Hospital, Copenhagen, Denmark
⁶Skåne University Hospital, Lund, Sweden
⁷Department of Oncology, Oslo University Hospital, Oslo, Norway
⁸St. Olavs Hospital, Trondheim, Norway
⁹Odense University Hospital, Odense, Denmark
¹⁰Roskilde Hospital, Roskilde, Denmark
¹¹Tampere University Hospital, Tampere, Finland
¹²Haukeland University Hospital, Bergen, Norway
¹³Turku University Hospital, Turku, Finland
¹⁴Department of Haematology, Rigshospitalet, Copenhagen, Denmark

Andrew J Davies, BSc, BM, FRCP, PhD^1*, Louise Stanton, MSc^2*, Josh Caddy, BSc^2*, Sharon Barrans, PhD^3*, Sam Wilding, MSc, PhD^4*, Geoff N Saunders, MSc^2*, Christoph Mamot, M.D.^5,6*, Urban Novak^6,7*, Andrew K. McMillan, MD⁸, Paul A Fields, MD, PhD⁹, Graham P. Collins, MBBS, MA, MRCP, FRCPath, DPhil¹⁰, Richard Stephens^11*, Francesco Cucco, PhD^12*, Chulin Sha, PhD^13*, Moniek Van Hoppe, MSc^3*, Reuben M Tooze, PhD^3*, Matthew A Care, PhD, MSc, BSc^14*, Gareth Griffiths, PhD^2*, Anna Schuh, MD, PhD, FRCP, FRCPath¹⁵, Ming-Qing Du, PhD¹², David R Westhead, D. Phil. M.A.^14*, Cathy Burton, MBBChir, MA, MD, FRCPath^3* and Peter Johnson, MD, FRCP¹⁶

¹CRUK Experimental Cancer Medicines Centre, University of Southampton, Southampton, United Kingdom
²Cancer Research UK Southampton Clinical Trials Unit, University of Southampton, Southampton, United Kingdom
³Haematological Malignancy Diagnostic Service, Leeds Cancer Centre, Leeds Teaching Hospitals NHS Trust, Leeds, United Kingdom
⁴CRUK Southampton Clinical Trials Unit, University of Southampton, Southampton, United Kingdom
⁵Medical Oncology, Cantonal Hospital Aarau, Switzerland
⁶The Swiss Group for Clinical Cancer Research (SAKK), Bern, Switzerland
⁷Department of Medical Oncology, Inselspital, Bern University Hospital, University of Bern, Bern, Switzerland
⁸Department of Haematology, Nottingham University Hospitals NHS Trust, Nottingham, United Kingdom
⁹Department of Haematology, Guy's and St. Thomas' NHS Foundation Trust, Kings Health Partners, London, United Kingdom
¹⁰Department of Clinical Haematology, Oxford University Hospitals, Oxford, United Kingdom
¹¹Patient Representative, NCRI Consumer Forum, London, United Kingdom
¹²Division of Cellular and Molecular Pathology, Department of Pathology, University of Cambridge, Cambridge, United Kingdom
¹³Institute of Basic Medicine and Cancer, Chinese Academy of Sciences, Hangzhou, China
¹⁴School of Molecular and Cellular Biology and Leeds Institute of Data Analytics, University of Leeds, Leeds, United Kingdom
¹⁵Department of Oncology, University of Oxford, Oxford, United Kingdom
¹⁶Cancer Research UK Experimental Cancer Medicines Centre UK, Southampton, United Kingdom

Elisabeth Schorb, MD^1*, Lisa Isbell, MD^1*, Andrea Kerkhoff, MD^2*, Stephan Mathas, MD^3*, Friederike Braulke, MD^4,5*, Gerlinde Egerer, MD^6*, Alexander Roeth, MD⁷, Simon Christian Schliffke, MD^8*, Peter Borchmann⁹, Uta Brunnberg, MD^10*, Frank P. Kroschinsky, MD, MBA¹¹, Robert Möhle, MD¹², Andreas Rank, MD^13*, Dominique Wellnitz, MD^14*, Benjamin Kasenda, MD PhD^15*, Lisa Pospiech^16*, Julia Wendler, MD^16*, Gabriele Ihorst^1,17*, Florian Scherer, MD^1*, Martina Deckert, MD^18*, Elina Henkes, MD^19*, Justus Duyster^1*, Jürgen Finke, MD, PhD¹ and Gerald Illerhaus, MD¹⁶

¹Department of Hematology, Oncology and Stem Cell Transplantation, Faculty of Medicine, University of Freiburg, Freiburg, Germany
²Department of Medicine A, Hematology, Oncology and Pneumology, University Hospital Muenster, Muenster, Germany
³Hematology, Oncology, and Tumor Immunology, Charité-Universitätsmedizin Berlin, Berlin, Germany
⁴Comprehensive Cancer Center, University Medicine of Göttingen, Göttingen, AL, Germany
⁵Department of Hematology and Medical Oncology, University Medical Center Göttingen, Göttingen, Germany
⁶Department of Hematology, Oncology and Rheumatology, Heidelberg University, Heidelberg, Germany
⁷Department of Hematology, University Hospital Essen, Essen, Germany
⁸Department of Oncology and Hematology, BMT With Section Pneumology, University Cancer Center Hamburg, Hamburg, DEU
⁹German Hodgkin Study Group (GHSG), Department I of Internal Medicine, University Hospital Cologne, Cologne, Germany
¹⁰Department of Medicine 2, Hematology and Oncology, University Hospital Frankfurt, Frankfurt, Germany
¹¹Dresden University Hospital, Dresden, Germany
¹²Department of Hematology and Oncology, University of Tübingen, Tübingen, Germany
¹³Medical Clinic II, University Hospital of Augsburg, Augsburg, Germany
¹⁴University Hospital of Schleswig-Holstein, Kiel, DEU
¹⁵Department of Medical Oncology, University Hospital Basel, Basel, Switzerland
¹⁶Department of Hematology, Oncology and Palliative Care, Klinikum Stuttgart, Stuttgart, Germany
¹⁷Clinical Trials Unit, Faculty of Medicine and Medical Center, Freiburg, Germany
¹⁸Insitute of Neuropathology, Universitätsklinikum Köln, Köln, Germany
¹⁹Clinic for Neuroradiology, Klinikum Stuttgart, Freiburg, Germany

Max S. Topp¹, Monica Tani, MD^2*, Michael Dickinson, MD³, Nilanjan Ghosh, MD⁴, Armando Santoro, MD^5*, Antonio Pinto, MD^6*, Francesc Bosch, MD, PhD⁷, Christopher P. Fox^8*, Armando López-Guillermo, MD, PhD^9*, Claudia Carlucci^10*, Chun Wu^11*, Kathryn Humphrey^10*, Pauline Baumlin^12*, Martin Barrett^10*, Naseer Qayum^10* and Franck Morschhauser, MD, PhD^13*

¹Universitätsklinikum Würzburg, Würzburg, Germany
²Ospedale Santa Maria delle Croci, Ravenna, Italy
³Peter MacCallum Cancer Centre, Royal Melbourne Hospital and The University of Melbourne, Melbourne, Australia
⁴Levine Cancer Institute/Atrium Health, Charlotte, NC
⁵Humanitas University and IRCCS Humanitas Research Hospital, Humanitas Cancer Center, Milan, Italy
⁶Istituto Nazionale Tumori, Fondazione ‘G. Pascale’, IRCCS, Naples, Italy
⁷Hospital Universitari Vall d’Hebron, Barcelona, Spain
⁸Nottingham University Hospitals NHS Trust, Nottingham, United Kingdom
⁹Hospital Clínic de Barcelona, Barcelona, Spain
¹⁰Roche Products Ltd, Welwyn Garden City, United Kingdom
¹¹Roche (China) Holding Ltd., Shanghai, China
¹²F. Hoffmann-La Roche Ltd, Basel, Switzerland
¹³Hôpital Claude Huriez Univ. Lille, CHU Lille, ULR 7365 - GRITA - Groupe de Recherche sur les formes Injectables et les Technologies Associées and Centre Hospitalier Régional Universitaire de Lille, Lille, France

Adam J. Olszewski^1*, Abraham Avigdor, MD^2,3, Sunil Babu, MD^4*, Itai Levi^5*, Herbert Eradat, MD⁶, Uri Abadi^3,7*, Houston Holmes, MD^8*, Matthew McKinney, MD^9*, Dariusz Woszczyk^10*, Krzysztof Giannopoulos^11*, Wojciech Jurczak¹², Diana Dunshee^13*, Annie Yang^13*, Mingzhu Zhou^14*, Naseer Qayum^15*, Gila Sellam^16* and Netanel A. Horowitz^17*

¹Brown University, Providence, RI
²Sheba Medical Center, Ramat Gan, Israel
³Tel Aviv University, Tel Aviv, Israel
⁴Fort Wayne Medical Oncology and Hematology, Fort Wayne, IN
⁵Soroka University Medical Center, Be'er-Sheva, Israel
⁶University of California, Los Angeles, CA
⁷Meir Medical Center, Kfar Saba, Israel
⁸Texas Oncology/Baylor-Sammons Cancer Center, Dallas, TX
⁹Duke Cancer Institute, Durham, NC
¹⁰University of Opole, Provincial Hospital, Opole, Poland
¹¹Medical University of Lublin, Lublin, Poland
¹²Maria Sklodowska-Curie National Research Institute of Oncology, Krakow, Poland
¹³Genentech, Inc., South San Francisco, CA
¹⁴F. Hoffmann-La Roche, Ltd., Shanghai, China
¹⁵Roche Products Ltd, Welwyn Garden City, United Kingdom
¹⁶F. Hoffmann-La Roche, Ltd., Basel, Switzerland
¹⁷Rambam Healthcare Campus, Technion, Haifa, Israel